Insider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 30,000 Shares of Stock

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) Director Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $9.56, for a total value of $286,800.00. Following the sale, the director now directly owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. This trade represents a 19.13 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Viemed Healthcare Trading Down 2.3 %

NASDAQ VMD opened at $8.85 on Friday. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The stock has a 50-day moving average of $8.37 and a 200-day moving average of $7.54. The firm has a market cap of $344.59 million, a PE ratio of 32.78 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The company had revenue of $58.00 million for the quarter.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. National Bank of Canada FI lifted its holdings in shares of Viemed Healthcare by 91.2% during the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after buying an additional 1,596 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in shares of Viemed Healthcare by 5.6% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock valued at $222,000 after buying an additional 1,601 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of Viemed Healthcare by 14.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company’s stock valued at $98,000 after buying an additional 1,912 shares during the period. Victory Capital Management Inc. raised its holdings in Viemed Healthcare by 21.1% in the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after purchasing an additional 2,226 shares during the period. Finally, Panagora Asset Management Inc. raised its holdings in Viemed Healthcare by 1.1% in the 2nd quarter. Panagora Asset Management Inc. now owns 272,383 shares of the company’s stock worth $1,784,000 after purchasing an additional 2,904 shares during the period. Hedge funds and other institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Articles

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.